ArticleEcancermedicalscience2025

Bevacizumab in recurrent epithelial ovarian cancer: real-world experience from a tertiary cancer hospital in India.

Ranti Ghosh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.